Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | ESR1 | P03372 | 4/20 | 0.68 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.68 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | HTR3A | P46098 | 1/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2281085 | 0.85 | TDP1 (0.71) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL1428981 | 0.84 | ESR1 (0.62) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL6964959 | 0.82 | ESR1 (0.59) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL69344 | 0.82 | ESR1 (1.00) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL30932186 | 0.82 | TDP1 (0.67) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL3873458 | 0.82 | ESR1 (1.00) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL11557511 | 0.80 | ESR1 (0.63) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL9143112 | 0.80 | ESR1 (0.63) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL1171632 | 0.80 | ESR1 (0.63) | KMT2AMEN1ESR1ESR2CA2 | |
| SCHEMBL1172696 | 0.80 | ESR1 (0.63) | KMT2AMEN1ESR1ESR2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113398284-B | Molecular probe for tumor targeted nuclide diagnosis and treatment, preparation method and application | 江苏省原子医学研究所 | 2023-04-14 | — | — | CN | claimed |
| CN-113683491-A | Preparation method of 4- (2-bromoethyl) phenol | 王传良 | 2021-11-23 | — | — | CN | claimed |
| CN-113683522-A | Preparation method of N-methyltyramine hydrochloride | 广汉市派瑞林科技有限责任公司 | 2021-11-23 | — | — | CN | claimed |
| CN-113620821-A | Preparation method of hordenine hydrochloride | 广汉市派瑞林科技有限责任公司 | 2021-11-09 | — | — | CN | claimed |
| CN-113398284-A | Molecular probe for tumor targeted nuclide diagnosis and treatment, preparation method and application | 江苏省原子医学研究所 | 2021-09-17 | — | — | CN | claimed |
| CN-101190923-B | Asymmetric bridged dinuclear metallocene compound, preparation thereof and application thereof in olefin polymerization | PETROCHINA CO LTD | 2010-11-03 | — | — | CN | claimed |
| CN-101190923-A | Asymmetric bridged dinuclear metallocene compound, preparation thereof and application thereof in olefin polymerization | CHINA PETROLEUM GAS CO LTD (CN) | 2008-06-04 | — | — | CN | claimed |
| CN-101190930-A | Dinuclear metallocene compound, preparation thereof and application thereof in olefin polymerization | CHINA PETROLEUM GAS CO LTD (CN) | 2008-06-04 | — | — | CN | claimed |
| US-20260132240-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | SHPP GLOBAL TECH B V (NL) | 2026-05-14 | — | — | US | disclosed |
| US-12623212-B2 | Physically reinforced structured organic film (SOF) anion exchange membranes (AEMs) | XEROX CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4702022-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | Halda Therapeutics Opco, Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20260028338-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12528815-B2 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer | NXERA PHARMA UK LIMITED (GB) | 2026-01-20 | — | — | US | disclosed |
| US-20250304613-A1 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE CONJUGATION APPROACH | ALNYLAM PHARMACEUTICALS, INC. (US) | 2025-10-02 | — | — | US | disclosed |
| US-3933897-A | ANTIULCER, ASTHMA, RENAL DYSFUNCTION | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933895-A | PROSTAGLANDINS, ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933900-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933898-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933899-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933896-A | ANTICOAGULANTS, ASTHMA, LABOR INDUCERS, CERVICAL DILATION | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12623212-B2 | Physically reinforced structured organic film (SOF) anion exchange membranes (AEMs) | EPCAM, SGMS1, PEF1 | KMT2A 4515/4885MEN1 4634/4885ESR1 674/4885 |
| US-20260028338-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, HCCS | KMT2A 3832/4885MEN1 2321/4885ESR1 3527/4885 |
| US-12528815-B2 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer | ADORA1, ADORA3, OPRL1 | KMT2A 3358/4885MEN1 3935/4885ESR1 3954/4885 |
| US-20250304613-A1 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE CONJUGATION APPROACH | AOC2, RTCB, AOC3 | KMT2A 2172/4885MEN1 3651/4885ESR1 610/4885 |
| US-20260132240-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | CBLB, UBE4A, PSMD14 | KMT2A 1729/4885MEN1 4470/4885ESR1 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.